Penny Stock's Critical Report on SWINGPLANE VENTURES, FANNIE MAE PFD S, Cord Blood America, RXi Pharmaceuticals

Hamilton, HM -- (SBWIRE) -- 03/12/2013 -- PennyStockWatchMan.com is an investment community with a special focus on updating investors winning trading ideas, and issues Stock Alert on the stocks that run high. Today our focus is on following stocks, SWINGPLANE VENTURES(OTC:SWVI), FANNIE MAE PFD S (OTC:FNMAS), Cord Blood America Inc.(OTC:CBAI), RXi Pharmaceuticals Corp(OTC:RXII)

SWINGPLANE VENTURES(OTC:SWVI)decreased-12.00% and closed at $0.110traded of 25.61 million shares of average trading volume. The company has a total market capitalization of $25.85 million.

The 52-week range for the stock is $0.097 and $1.00, and during previous trading session stocks touched its highest price at $0.13. Its introductory price for the day was $0.10.Swingplane Ventures, Inc., an exploration stage company, engages in the exploration and production of mineral properties in Chile. The company primarily explores for copper.

Why Should Investors Buy SWVI After the Recent Fall? Just Go Here and Find Out

FANNIE MAE PFD S (OTC:FNMAS)jumped up+2.67% and closed at $1.92. So far in three months, the stock is up down+16.36%. The 52-week range for the stock is $0.46 and $2.53, and during previous trading session stocks touched its highest price at $1.95. Its introductory price for the day was $1.85. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support in the secondary mortgage market in the United States.

For How Long FNMAS’s Gloss will Attract Investors? Find out via this report

Cord Blood America Inc.(OTC:CBAI) remained a bear for the day as it reported the loss momentum of -4.76% and closed at $0.0040.Its introductory price for the day was $0.0036. So far the company’s stock is up +17.65% in three months period, in last 6 months of trade in reported a decline of -69.23%. Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families throughout the United States and internationally in South America, China, Germany, and Spain.

Will CBAI Get Buyers Even After The Recent Rally? Find Out Here

RXi Pharmaceuticals Corp(OTC:RXII)ended its day with the gaining stream with the riseof +37.57% and closed at the price of $0.275 after opening at $0.2049. Stock traded during its average volume of 930,642.00 shares.

During the previous session company’s minimum price was $0.2001 while it touched its highest price for the day at $0.285. RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform.

Will RXII Continue To Move Higher? Find Out Here

About PennyStockWatchMan.com
PennyStockWatchMan.com goal is simple: pick stocks poised to move explosively and present them to you. We dive in and out of promo/momo campaigns, play on disruptive news, sniff out unusual trading activity like insiders buying, and have a large network of traders, promoters and savvy players that give us a proprietary edge over any other penny stock site. Our edge is your edge. Go ahead and sign-up to our competitor’s alerts. When they fail, come back and see how we make money with penny stocks.

Disclaimer
First things first – before viewing any of our information or subscribing to our alerts, you agree and fully understand that financial markets contain risk. That being said and agreed upon, if you directly or indirectly use the information on this website or this site’s newsletters or Press Release issued by us. You shall not hold PennyStockWatchman.com or any of its affiliates liable for any loss, injury, or damage resulting from the use of this website or newsletters emanating from this website.

Please read our full disclaimer at http://www.pennystockwatchman.com/disclaimer/